Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J GELLER

Showing results (1-10 of 323) with videos related to

Pageof 33
Sort By:
Cancer|February 1, 1993
Basis for hormonal management of advanced prostate cancerJ Geller
Journal of the American Geriatrics Society|December 1, 1991
Benign prostatic hyperplasia: pathogenesis and medical therapyJ Geller
Cancer|July 1, 1992
Nonsurgical treatment of prostatic hyperplasiaJ Geller
Trends in Endocrinology and Metabolism: TEM|April 15, 2008
A search for gems in a sea of shifting sandJ Geller
Seminars in Oncology|March 1, 1985
Rationale for blockade of adrenal as well as testicular androgens in the treatment of advanced prostate cancerJ Geller
The Journal of Clinical Endocrinology and Metabolism|December 1, 1990
Effect of finasteride, a 5 alpha-reductase inhibitor on prostate tissue androgens and prostate-specific antigenJ Geller
Journal of Andrology|November 1, 1991
Overview of enzyme inhibitors and anti-androgens in prostatic cancerJ Geller
The Urologic Clinics of North America|February 1, 1991
Megestrol acetate plus low-dose estrogen in the management of advanced prostatic carcinomaJ Geller
The American Journal of Psychiatry|April 1, 1984
Arson: an unforeseen sequela of deinstitutionalizationJ Geller
European Urology|January 1, 1995
Five-year follow-up of patients with benign prostatic hyperplasia treated with finasterideJ Geller
Pageof 33

Showing results (1-10 of 323) with videos related to

Sort By:
Pageof 33
Cancer|February 1, 1993
Basis for hormonal management of advanced prostate cancerJ Geller
Journal of the American Geriatrics Society|December 1, 1991
Benign prostatic hyperplasia: pathogenesis and medical therapyJ Geller
Cancer|July 1, 1992
Nonsurgical treatment of prostatic hyperplasiaJ Geller
Trends in Endocrinology and Metabolism: TEM|April 15, 2008
A search for gems in a sea of shifting sandJ Geller
Seminars in Oncology|March 1, 1985
Rationale for blockade of adrenal as well as testicular androgens in the treatment of advanced prostate cancerJ Geller
The Journal of Clinical Endocrinology and Metabolism|December 1, 1990
Effect of finasteride, a 5 alpha-reductase inhibitor on prostate tissue androgens and prostate-specific antigenJ Geller
Journal of Andrology|November 1, 1991
Overview of enzyme inhibitors and anti-androgens in prostatic cancerJ Geller
The Urologic Clinics of North America|February 1, 1991
Megestrol acetate plus low-dose estrogen in the management of advanced prostatic carcinomaJ Geller
The American Journal of Psychiatry|April 1, 1984
Arson: an unforeseen sequela of deinstitutionalizationJ Geller
European Urology|January 1, 1995
Five-year follow-up of patients with benign prostatic hyperplasia treated with finasterideJ Geller
Pageof 33